Search all medical codes

Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)

HCPCS code

Name of the Procedure:

Common Name: Flu Vaccine, Fluvirin
Technical/Medical Term: Influenza Virus Vaccine, Split Virus, Administered Intramuscularly (Q2037)

Summary

The flu vaccine, specifically Fluvirin, is an intramuscular shot administered to individuals aged 3 years and older to protect against influenza, commonly known as the flu.

Purpose

Medical Conditions: The flu vaccine is used to prevent influenza, a contagious respiratory illness caused by influenza viruses.
Goals/Outcomes: The goal is to reduce the risk of flu-related complications, hospitalizations, and the spread of the virus within the community.

Indications

Symptoms: High fever, cough, sore throat, muscle aches, fatigue.
Patient Criteria: Individuals aged 3 years and older, especially those with chronic health conditions, the elderly, pregnant women, and healthcare workers.

Preparation

Pre-Procedure Instructions: Generally, no specific preparations are needed. Inform your healthcare provider of any allergies or prior adverse reactions to vaccines.
Diagnostic Tests: None required, but a brief medical history review is essential.

Procedure Description

  1. Preparation: The healthcare provider will prepare the Fluvirin vaccine.
  2. Administration: The vaccine is injected into the muscle of the upper arm (deltoid muscle).
  3. Equipment: Sterile needle and syringe, Fluvirin vaccine vial.
  4. Anesthesia/Sedation: None required; the procedure is quick and minimally painful.

Duration

The injection process typically takes a few minutes.

Setting

The vaccine can be administered in various settings, including:

  • Hospitals
  • Outpatient Clinics
  • Community Health Centers
  • Pharmacies

Personnel

Typically administered by:

  • Nurses
  • Medical Assistants
  • Pharmacists

Risks and Complications

Common Risks:

  • Soreness at the injection site
  • Mild fever
  • Fatigue

Rare Risks:

  • Severe allergic reactions (anaphylaxis)
  • Guillain-Barré Syndrome (extremely rare)

Management: Any adverse reactions should be reported to the healthcare provider immediately.

Benefits

Expected Benefits:

  • Reduced risk of contracting influenza
  • Decreased severity if one does get flu Timeframe: Immunity generally develops within two weeks post-vaccination.

Recovery

Post-Procedure Care: Monitor the injection site for redness or swelling. Over-the-counter pain relief (e.g., acetaminophen) can be used if necessary.
Recovery Time: Immediate; individuals can typically resume normal activities right away.
Restrictions/Follow-up: None, but yearly vaccination is recommended.

Alternatives

Other Options:

  • Live-attenuated influenza vaccine (nasal spray)
  • Other intramuscular or intradermal flu vaccine brands

Pros and Cons:

  • Nasal Spray: Suitable for those who fear needles but not for immunocompromised individuals.
  • Other Brands: Equally effective but choice may depend on availability and individual health conditions.

Patient Experience

During Procedure: Brief discomfort from the needle prick.
After Procedure: Mild soreness at the injection site is common. Hydrate well and inform your healthcare provider of any unusual symptoms. Pain can usually be managed with OTC pain relievers.

Similar Codes



Contact us to learn more

Choose your own adventure

Email

Send us a message or questions and we can share more details.

Meet

Setup a calendar meeting with us; find a time now.